Rachel Guy

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent. Top assignees: Bio-Technology General Corporation, Bio-Technology General (Israel) Ltd., Savient Pharmaceuticals, Inc.. Active years: 1993-2006.

USPTO Granted Patents = 9

% Patents Active = 88.9

CIPO Patents = 1

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 91(Granted Patents)

Company Filing History:

7 out of 67

Bio-Technology General Corporation

patents

1 out of 3

Bio-Technology General (Israel) Ltd.

patents

1 out of 13

Savient Pharmaceuticals, Inc.

patents

Years Active: 1993-2006

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7132510 - Specific human antibodies for selective cancer therapy (2006-11-07),

2. 7087722 - Fibrin binding domain polypeptides and uses and methods of producing same (2006-08-08),

3. 6121426 - Fibrin binding domain polypeptides and uses and methods of producing same (2000-09-19),

4. 5965383 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-10-12),

5. 5869616 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-02-09),

6. 5801017 - Production of recombinant factor Xa inhibitor of leech Hirudo (1998-09-01),

7. 5679320 - Fibrin binding domain polypeptides and uses and methods of producing same (1997-10-21),

8. 5455158 - Fibrin binding domain polypeptides and uses and methods of producing same (1995-10-03),

9. 5270030 - Fibrin binding domain polypeptide and method of producing (1993-12-14),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]